Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Lack of Cisd2 disrupts calcium balance in cells, leading to poorly functioning neutrophils.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Midazolam impairs learning and memory by increasing neurosteroids through specific receptor activation.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.